Sanguisorba officinalis L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways
Sanguisorba officinalis L., a traditional Chinese medicine (TCM) called DiYu (DY) in China, has a strong tradition of utilization as a scorching, blood-cooling, and hemostatic medication, and was used for cancer prevention and treatment due to its potential immune-enhancing and hematological toxicit...
Main Authors: | Weijia Zhang, Ling Ou, Chang Peng, Shuyi Sang, Zhong Feng, Yuanjing Zou, Yuemei Yuan, Hao Li, Guimin Zhang, Meicun Yao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023040057 |
Similar Items
-
Characterization of an herbplant chloroplast genome of Sanguisorba officinalis
by: Wanyang Li, et al.
Published: (2020-04-01) -
Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer
by: Weijia Zhang, et al.
Published: (2022-05-01) -
In vitro anti‐bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection
by: Xue Shen, et al.
Published: (2021-04-01) -
A Comprehensive Review of Genus Sanguisorba: Traditional Uses, Chemical Constituents and Medical Applications
by: Ping Zhou, et al.
Published: (2021-09-01) -
Determination of free and bounded phenolic acids in the rhizomes and herb of Sanguisorba officinalis L.
by: Biernasiuk Anna, et al.
Published: (2015-12-01)